SUBSCRIBE
SUBSCRIBE

Missouri

Signage outside Express Scripts' headquarters in Missouri
Pharmacy benefit managers
Cigna to Remove AbbVie’s Humira From Formularies, Putting More Pressure on Blockbuster
Mirroring fellow pharmacy benefit manager CVS Caremark, Cigna’s Express Scripts is taking Humira off its major commercial formularies starting next year and focusing on more affordable biosimilar options.
August 27, 2024
 · 
2 min read
 · 
Tristan Manalac
PRESS RELEASES
Business
CENTENE TO PRESENT AT BANK OF AMERICA 2024 GLOBAL HEALTHCARE CONFERENCE
September 11, 2024
 · 
1 min read
Press Releases
Stereotaxis to Present at Upcoming Investor Conferences
September 9, 2024
 · 
2 min read
Press Releases
Vivacelle Bio Enrolls First Patient in Phase 3 Trial of Hypovolemia Due to Septic Shock for Phospholipid Nanoparticle-Based VBI-S
September 3, 2024
 · 
6 min read
Business
CENTENE TO PRESENT AT 2024 WELLS FARGO HEALTHCARE CONFERENCE
August 29, 2024
 · 
1 min read
Business
Stereotaxis Reports 2024 Second Quarter Financial Results
August 12, 2024
 · 
7 min read
News
Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX
August 12, 2024
 · 
4 min read
Press Releases
Vivacelle Bio Initiates Phase 3 Trial for Lead Asset VBI-S to Treat Patients with Hypovolemia Due to Septic Shock
July 23, 2024
 · 
5 min read
Business
Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
July 22, 2024
 · 
1 min read
Press Releases
Stowers scientists uncover fundamental rules for how dengue virus infects its mosquito and human hosts
July 22, 2024
 · 
5 min read
Press Releases
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
July 19, 2024
 · 
3 min read
News
Multi-Cancer Early Detection Blood Test May Increase Cancer Screening Equity
July 15, 2024
 · 
3 min read
Press Releases
Peer-Reviewed Study Confirms Reliability of ColoSense, Geneoscopy’s Noninvasive Multi-target Stool RNA Colorectal Cancer Screening Test
July 10, 2024
 · 
2 min read
Press Releases
C2N Diagnostics Says FDA’s Approval of Donanemab Highlights Its Role in Helping to Determine Alzheimer’s Disease Pathology
July 2, 2024
 · 
4 min read
Press Releases
CENTENE CORPORATION TO HOST 2024 SECOND QUARTER FINANCIAL RESULTS EARNINGS CALL
July 2, 2024
 · 
2 min read
BioMidwest
Vivacelle Bio’s President and Chief Innovation Officer to Present Data Highlighting the Company’s Late-Stage Clinical Programs at the BIO International Convention 2024
May 31, 2024
 · 
4 min read
Business
Stowers Institute for Medical Research appoints new Assistant Investigator
April 30, 2024
 · 
3 min read
Drug Development
Vivacelle Bio and University of Missouri-Kansas City School of Medicine Announce Groundbreaking Results from Phase 2a Clinical Trial of VBI-S for Refractory Hypotension in Severe Septic Shock Patients
February 29, 2024
 · 
5 min read
BioMidwest
Defender Pharmaceuticals Receives Complete Response Letter from the U.S. Food and Drug Administration for its Intranasal Scopolamine (DPI-386) New Drug Application for the Prevention of Nausea and Vomiting Induced by Motion in Adults
January 30, 2024
 · 
4 min read
Business
Geneoscopy and Adiso Therapeutics Announce Strategic Collaboration to Investigate New Therapeutic Options for Patients with Inflammatory Bowel Disease
December 5, 2023
 · 
5 min read
Business
Kansas City University Recognized for “Groundbreaking” Pancreatic Cancer Research
August 24, 2023
 · 
3 min read
Load More